Bo Gao

Active 1986–2026

920
Papers
56,190
Citations
114
h-index
546
i10-index

Citations

Citations per year for Bo Gao1975: 1 citations1977: 1 citations1987: 4 citations1988: 10 citations1989: 9 citations1990: 8 citations1991: 9 citations1992: 24 citations1993: 18 citations1994: 17 citations1995: 12 citations1996: 12 citations1997: 10 citations1998: 6 citations1999: 11 citations2000: 31 citations2001: 64 citations2002: 111 citations2003: 124 citations2004: 105 citations2005: 118 citations2006: 67 citations2007: 80 citations2008: 77 citations2009: 133 citations2010: 157 citations2011: 211 citations2012: 287 citations2013: 310 citations2014: 427 citations2015: 371 citations2016: 332 citations2017: 439 citations2018: 489 citations2019: 1,203 citations2020: 1,792 citations2021: 2,226 citations2022: 2,213 citations2023: 1,858 citations2024: 2,930 citations2025: 1,885 citations2026: 173 citations2027: 1 citations1976: no citations, so this year is not shown1978–1986: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorChina: 6,692 citing papers, 25.9% of this breakdownUnited States: 4,804 citing papers, 18.6% of this breakdownUnited Kingdom: 1,168 citing papers, 4.5% of this breakdownGermany: 1,005 citing papers, 3.9% of this breakdownItaly: 870 citing papers, 3.4% of this breakdownJapan: 837 citing papers, 3.2% of this breakdownCanada: 760 citing papers, 2.9% of this breakdownFrance: 737 citing papers, 2.9% of this breakdownIndia: 673 citing papers, 2.6% of this breakdownAustralia: 669 citing papers, 2.6% of this breakdownSpain: 613 citing papers, 2.4% of this breakdownSouth Korea: 526 citing papers, 2% of this breakdown
0%25.9%Other 25.1%

Fields

  • Medicine38.5%
  • Biochemistry, Genetics and Molecular Biology18.7%
  • Computer Science12.2%
  • Engineering10.8%
  • Environmental Science3.4%
  • Neuroscience3.4%
  • Other13%

Topics

  • Cancer Immunotherapy and Biomarkers3.9%
  • Lung Cancer Treatments and Mutations1.1%
  • Head and Neck Cancer Studies1%
  • Lung Cancer Research Studies1%
  • Immunotherapy and Immune Responses0.9%
  • MicroRNA in disease regulation0.8%
  • Other91.3%

Coauthors

All papers

Open in search
  1. Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bo Gao, Brett Hughes, Girish Mallesara, Danny Rischin, Anne L. Taylor, Martin Burian, Thorsten Fuereder, Richard Greil, Carlos H. Barrios, Dalvaro Oliveira de Castro Junior, Gilberto de Castro, Fábio Franke, Gustavo Girotto, Iane Pinto Figueiredo Lima, Ulisses Ribaldo Nicolau, Gustavo Dix Junqueira Pinto, Lucas Vieira dos Santos, Ana-Paula Victorino, Neil Chua, Félix Couture, Richard Gregg, Aaron R. Hansen, John Hilton, Joy McCarthy, Denis Soulières, Rodrigo Ascuí, Pablo Gonzalez, Luis J. Villanueva-Rivera, Marco Torregroza, Ángela R. Zambrano, Petra Holečková, Zdeněk Král, Bohuslav Melichar, Prausova Jana, Milan Vošmik, Maria Andersen, Niels Gyldenkerne, Hannes Jürgens, Kadri Putnik, Petri Reinikainen, Viktor Gruenwald, Simon Laban, Gerasimos Aravantinos, Ioannis Boukovinas, Vassilis Georgoulias, Amanda Psyrri, D.L.W. Kwong, Yousuf Al-Farhat, Tibor Csőszi, József Erfán, Geza Horvai, László Landherr, Éva Remenár, Ágnes Ruzsa, Judit Szota, Salem Billan, Iris Gluck, Orit Gutfeld, Aron Popovtzer, Marco Benasso, Simona Bui, Vittorio Ferrari, Lisa Licitra, Franco Nolè, Takashi Fujii, Yasushi Fujimoto, Nobuhiro Hanai, Hiroki Hara, Koji Matsumoto, Kenji Mitsugi and 119 more - The Lancet 2019 cited by 3,211

  2. Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair–Deficient Cancer: Results From the Phase II KEYNOTE-158 Study

    Authors: , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2019 cited by 2,963

  3. Cemiplimab monotherapy for first-line treatment of advanced non-small-cell lung cancer with PD-L1 of at least 50%: a multicentre, open-label, global, phase 3, randomised, controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2021 cited by 799

  4. PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Víctor Moreno, Jiaxin Niu, Taofeek K. Owonikoko, Kyriakos P. Papadopoulos, George D. Yancopoulos, Israel Lowy, Matthew G. Fury - New England Journal of Medicine 2018 cited by 1,393

  5. Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sophia Frentzas, Ganessan Kichendasse, Bo Gao, Tarek Meniawy, Linda Mileshkin, Gary Richardson, Felicia Roncolato, Jean‐François Baurain, Maryam Bourhaba, Eveline Cuypere, Philip R. Debruyne, Hannelore Denys, Frédéric Forget, Brigitte Honhon, E. Joosens, Els Van Nieuwenhuysen, Vanessa da Costa Miranda, Andréia Cristina de Melo, Joao Daniel Guedes, Charles Andreé Joseph de Pádua, Nicolas Lazaretti, Carolina Martins Vieira, André Mattar, Daniela Neves Palmeiro, Christina Pimentel Oppermann Kussler, Pedro Emanuel Rubini Liedke, João Soares Nunes, Katsuki Arima Tiscoski, Allan Covens, Lara De Guerké, Prafull Ghatage, Lucy Gilbert, Susie Lau, Amit M. Oza, Diane Provencher, Omar Touhami, Congzhu Li, Danbo Wang, Ge Lou, Zhu Genhai, Guiling Li, Shi Hong, Hong Zheng, Wen Hongwu, Jihong Liu, Jing Wang, Ke Wang, Jiang Kui, Li Li, Wang Li, Hao Min, Qi Zhou, Gao Qinglei, Sihai Liao, Zhang Songling, Zhao Weidong, Xiaohua Wu, Wuliang Wang, Rutie Yin, Cheng Ying, Yu Zhang, Liang Zhiqing, Fernando Contreras Mejía, Ángel Luis Martín de Francisco Hernández, Carolina Ortiz Lopez, Carlos Javier Pacheco, Pedro Luis Ramos Guette, Jaime Rendon Pereira, Julian Rivera Diaz, Tomás Sánchez Villegas and 156 more - Journal of Clinical Oncology 2023 cited by 331

  6. Piezo1/2 mediate mechanotransduction essential for bone formation through concerted activation of NFAT-YAP1-ß-catenin

    Authors: , , , , , , , , , , , , , , , - eLife 2020 cited by 359

  7. QTune: A Query-Aware Database Tuning System with Deep Reinforcement Learning

    Authors: , , , - VLDB Endowment, Proc. VLDB Endow. 2019 cited by 235

  8. Subchondral bone osteoclasts induce sensory innervation and osteoarthritis pain

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2018 cited by 451

  9. Cemiplimab plus chemotherapy versus chemotherapy alone in non-small cell lung cancer: a randomized, controlled, double-blind phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2022 cited by 301

  10. Driving Style Recognition for Intelligent Vehicle Control and Advanced Driver Assistance: A Survey

    Authors: , , , , - IEEE Transactions on Intelligent Transportation Systems, IEEE Trans. Intell. Transp. Syst. 2017 cited by 611

  11. Bone mesenchymal stem cells stimulation by magnetic nanoparticles and a static magnetic field: release of exosomal miR-1260a improves osteogenesis and angiogenesis

    Authors: , , , , , , , , , , , - Journal of Nanobiotechnology 2021 cited by 258

  12. A gut microbial signature for combination immune checkpoint blockade across cancer types

    Authors: , , , , , , , , , , , , , , , , , - Nature Medicine 2024 cited by 127

  13. Sum-Rate Maximization in STAR-RIS-Assisted RSMA Networks: A PPO-Based Algorithm

    Authors: , , , , , - IEEE Internet of Things Journal, IEEE Internet Things J. 2023 cited by 72

  14. Prostaglandin E2 mediates sensory nerve regulation of bone homeostasis

    Authors: , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2019 cited by 306

  15. Apoptotic bodies derived from mesenchymal stem cells promote cutaneous wound healing via regulating the functions of macrophages

    Authors: , , , , , , , , , , , , , , , - Stem Cell Research & Therapy 2020 cited by 178

  16. Exosomes Derived from Bone Mesenchymal Stem Cells with the Stimulation of Fe3O4 Nanoparticles and Static Magnetic Field Enhance Wound Healing Through Upregulated miR-21-5p

    Authors: , , , , , , , , , , , - International Journal of Nanomedicine 2020 cited by 201

  17. Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Margaret McGrath, Richard Greil, Dietmar Thurnher, Thorsten Fuereder, Martin Burian, Sylvie Rottey, Jean‐Pascal Machiels, Paul Clement, Stéphanie Henry, S. Deheneffe, Gustavo Vasconcelos Alves, Iane Pinto Figueiredo Lima, Josiane Mourão Dias, Pedro Rafael Martins De Marchi, Milena Perez Mak, Andrea Juliana Gomes, Dalvaro Oliveira de Castro Junior, Tatiane Cardoso Motta, Mônica Luciana Agostinho Padoan, Ana Paula Victorina, Sérgio Jobim Azevedo, Lillian L. Siu, Stephanie Yasmin Brule, John Hilton, Chang Shu Wang, Nathaniel Bouganim, Marc Webster, John Walker, Neil Chua, Ángela R. Zambrano, Alicia Quiroga Echeverri, Oscar Mauricio Niño Gomez, Carlos Alberto Ortiz, Luis Alejandro Rojas, Andrés Cardona Zorilla, Olga Marcela Urrego Meléndez, Petra Holečková, Bohuslav Melichar, Jakub Cvek, Jana Prausová, Milan Vošmik, Jean‐Pierre Delord, Xavier Zasadny, Lionnel Geoffrois, Yungan Tao, Y. Pointreau, Rainer Fietkau, Marlen Haderlein, Andreas Müller, Ursula C. Schroeder, Barbara Wollenberg, Simon Laban, Philipp Ivanyi, Viktor Gruenwald, Philippe Schafhausen, Orit Gutfeld, Iris Gluck, Aron Popovtzer, Amichay Meirovitz, Salem Billan, Baruch Brenner, Aron Popovtzer, Dror Limon, Lisa Licitra, Francesco Perri, Francesco Caponigro, Martina Violati, Daris Ferrari, Franco Nolè, Federica Bertolini and 90 more - The Lancet Oncology 2024 cited by 210

  18. Joint Coordinated Beamforming and Power Splitting Ratio Optimization in MU-MISO SWIPT-Enabled HetNets: A Multi-Agent DDQN-Based Approach

    Authors: , , , , , - IEEE Journal on Selected Areas in Communications, IEEE J. Sel. Areas Commun. 2021 cited by 95

  19. An Overview of Dynamic Spectrum Sharing: Ongoing Initiatives, Challenges, and a Roadmap for Future Research

    Authors: , , , , - IEEE Transactions on Cognitive Communications and Networking, IEEE Trans. Cogn. Commun. Netw. 2016 cited by 271

  20. NLRP1 inflammasome contributes to chronic stress-induced depressive-like behaviors in mice

    Authors: , , , , , , , - Journal of Neuroinflammation 2020 cited by 203

  21. Pembrolizumab After Two or More Lines of Previous Therapy in Patients With Recurrent or Metastatic SCLC: Results From the KEYNOTE-028 and KEYNOTE-158 Studies

    Authors: , , , , , , , , , , , , , , , , , , , , - Journal of Thoracic Oncology 2019 cited by 438

  22. Deep Convolutional Neural Network-Based Epileptic Electroencephalogram (EEG) Signal Classification

    Authors: , , , , - Frontiers in Neurology 2020 cited by 214

  23. Beam Management in Millimeter-Wave Communications for 5G and Beyond

    Authors: , , , - IEEE Access 2020 cited by 175

  24. Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III TROPION-Lung01 Study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Daniel Brungs, Bo Gao, Adnan Nagria, Christos S. Karapetis, Sagun Parakh, Cheol Park, Gaëtan Catala, Frédéric Forget, Sebahat Ocak, Naveen S. Basappa, Geoffrey Liu, Ines B. Menjak, Benjamin Shieh, Shun Lü, Feng Luo, Hongmei Sun, Jialei Wang, Yu Yao, Milada Zemanová, Jaafar Bennouna, Nicolas Girard, Laurent Greillier, Corinne Lamour, H. Léna, Céline Mascaux, Julien Mazières, Denis Moro‐Sibilot, M. Pérol, Elvire Pons‐Tostivint, Virginie Westeel, Akin Atmaca, Christine Greil, Niels Reinmuth, Christian Schumann, Thomas Wehler, Juergen Wolf, James Ho, Csaba Böcskei, Federico Cappuzzo, Filippo de Marinis, Claudia Proto, Manlio Mencoboni, Silvia Novello, Stefania Salvagni, Héctor Soto Parrà, Haruko Daga, Yasushi Goto, Hidetoshi Hayashi, Satoru Kitazono, Kiyotaka Yoh, Ryo Ko, Masashi Kondo, Toshiyuki Kozuki, Takayasu Kurata, Hideaki Mizutani, Kadoaki Ohashi, Satoshi Oizumi, Isamu Okamoto, Satoshi Sakaguchi, H Ozasa, Shunichi Sugawara, Yuichi Tambo, Motohiro Tamiya, Hiroshi Tanaka, Isamu Okamoto, Froylán López-López, Francisco Javier Ramírez Godinez, Jerónimo Rafael Rodríguez Cid, Robin Cornelissen, Steven Gans and 61 more - Journal of Clinical Oncology 2024 cited by 182